No Need for Subacromial Decompression in Responders to Specific Exercise Treatment - A 10-year follow-up of a Randomized Clinical Trial
Subacromial pain is a common and disabling condition with multifactorial aetiology. Increasing evidence supports exercises as first-line treatment and need of surgery is debated. Long-term follow-ups after surgical- and non-surgical treatment are scarce. The primary aim of the present study was to i...
Gespeichert in:
Veröffentlicht in: | Journal of shoulder and elbow surgery 2024-12 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Subacromial pain is a common and disabling condition with multifactorial aetiology. Increasing evidence supports exercises as first-line treatment and need of surgery is debated. Long-term follow-ups after surgical- and non-surgical treatment are scarce. The primary aim of the present study was to investigate the 10-year outcomes after a study comparing specific and non-specific exercise treatment and the need for surgery. Secondarily we compared patients who had undergone exercise treatment, to those having surgery and explored the importance of rotator cuff status in relation to given treatment and outcomes.
At enrolment 2009-2010, 97 patients with long-standing subacromial pain were on the waiting list for Arthroscopic Subacromial Decompression (ASD). They were randomized to specific exercises focusing on strengthening of the rotator cuff and scapula stabilizers (n=51) or control: unloaded range of motion exercises (n=46). ASD was optional during the entire observation time. Eligible patients from either group constitute the present 10-year cohort with non-operated (n=42) or operated (n=41) patients. The primary outcome was shoulder function and pain after 10 years assessed by the Constant-Murley score (CMS). Secondary outcomes were proportion of patients choosing surgery and rotator cuff status related to treatment and primary outcome.
At the 10-year follow-up, 83 of 97 patients (86%) participated. All patients significantly improved in CMS from baseline to 10-year follow-up, mean improvement of 37 (95% CI 33-41, p |
---|---|
ISSN: | 1058-2746 1532-6500 1532-6500 |
DOI: | 10.1016/j.jse.2024.10.027 |